{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T12:22:20Z","timestamp":1648988540330},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/qai.0b013e3181a44700","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T07:32:57Z","timestamp":1248075177000},"page":"601-608","source":"Crossref","is-referenced-by-count":4,"title":["Blood and Seminal Plasma HIV-1 RNA Levels Among HIV-1-Infected Injecting Drug Users Participating in the AIDSVAX B\/E Efficacy Trial in Bangkok, Thailand"],"prefix":"10.1097","volume":"51","author":[{"given":"Wanitchaya","family":"Kittikraisak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frits","family":"van Griensven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"McNicholl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter B","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rutt","family":"Chuachoowong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suphak","family":"Vanichseni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruengpung","family":"Sutthent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan W","family":"Tappero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy D","family":"Mastro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale J","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Gurwith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwip","family":"Kitayaporn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udomsak","family":"Sangkum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kachit","family":"Choopanya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-14-20210131","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/508748","article-title":"Randomized, placebo-controlled efficacy trial of a bivalent rgp120 HIV-1 vaccine among injecting drug users in Bangkok, Thailand.","volume":"194","year":"2006","journal-title":"J Infect Dis"},{"key":"R2-14-20210131","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.","volume":"191","author":"Flynn","year":"2005","journal-title":"J Infect Dis"},{"key":"R3-14-20210131","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.290.5491.486","article-title":"Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.","volume":"290","author":"Barouch","year":"2000","journal-title":"Science"},{"key":"R4-14-20210131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.1058915","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine.","volume":"292","author":"Amara","year":"2001","journal-title":"Science"},{"key":"R5-14-20210131","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/415331a","article-title":"Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.","volume":"415","author":"Shiver","year":"2002","journal-title":"Nature"},{"key":"R6-14-20210131","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1086\/367891","article-title":"Key issues for a potential human immunodeficiency virus vaccine.","volume":"36","author":"Hu","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R7-14-20210131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00126334-200407010-00013","article-title":"Early markers of HIV-1 disease progression in a prospective cohort of seroconverters in Bangkok, Thailand: implications for vaccine trials.","volume":"36","author":"Buchacz","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-14-20210131","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00002030-200104130-00003","article-title":"Viral load differences in early infection with two HIV-1 subtypes.","volume":"15","author":"Hu","year":"2001","journal-title":"AIDS"},{"key":"R9-14-20210131","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00002030-200401230-00022","article-title":"Recruitment, screening and characteristics of injection drug users participating in the AIDSVAX B\/E HIV vaccine trial, Bangkok, Thailand.","volume":"18","author":"Vanichseni","year":"2004","journal-title":"AIDS"},{"issue":"RR-2","key":"R12-14-20210131","first-page":"1","article-title":"1997 Revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV).","volume":"46","year":"1997","journal-title":"MMWR Recomm Rep"},{"key":"R13-14-20210131","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1086\/514213","article-title":"Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood.","volume":"177","author":"Coombs","year":"1998","journal-title":"J Infect Dis"},{"key":"R14-14-20210131","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/JCM.28.3.495-503.1990","article-title":"Rapid and simple method for purification of nucleic acids.","volume":"28","author":"Boom","year":"1990","journal-title":"J Clin Microbiol"},{"key":"R15-14-20210131","first-page":"485","article-title":"Random regression models for human immunodeficiency virus ribonucleic acid data subject to left censoring and informative drop-outs.","volume":"49","author":"Lyles","year":"2000","journal-title":"Appl Stat"},{"key":"R16-14-20210131","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1089\/088922299309739","article-title":"Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression.","volume":"15","author":"Smith","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R17-14-20210131","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/sim.1394","article-title":"On the analysis of viral load endpoints in HIV vaccine trials.","volume":"22","author":"Hudgens","year":"2003","journal-title":"Stat Med"},{"key":"R18-14-20210131","first-page":"139","article-title":"The choice of statistical test illustrated on the interpretation of data classed in a 2 2 table.","volume":"34","author":"Pearson","year":"1947","journal-title":"Biometrika"},{"key":"R19-14-20210131","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2307\/2982890","article-title":"Fishers exact test.","volume":"155","author":"Upton","year":"1992","journal-title":"J Roy Statist Soc A"},{"key":"R20-14-20210131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/2331554","article-title":"The probable error of a mean.","volume":"6","year":"1908","journal-title":"Biometrika"},{"key":"R21-14-20210131","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/01621459.1979.10481038","article-title":"Robust locally weighted regression and smoothing scatterplots.","volume":"74","author":"Cleveland","year":"1979","journal-title":"J Am Stat Assoc"},{"key":"R22-14-20210131","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data.","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"key":"R23-14-20210131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using general linear models.","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"R24-14-20210131","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/3001968","article-title":"Individual comparisons by ranking methods.","volume":"1","author":"Wilcoxon","year":"1945","journal-title":"Biometrics Bull"},{"key":"R25-14-20210131","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2307\/2532940","article-title":"Applying Cox regression to competing risks.","volume":"51","author":"Lunn","year":"1995","journal-title":"Biometrics"},{"key":"R26-14-20210131","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/aid.1998.14.319","article-title":"HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity.","volume":"14","author":"Subbarao","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R27-14-20210131","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1089\/088922200308693","article-title":"Genetic characterization of incident HIV type 1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand.","volume":"16","author":"Subbarao","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R28-14-20210131","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/00365540410021054","article-title":"High plasma HIV load in the CRF01-AE outbreak among injecting drug users in Finland.","volume":"37","author":"Kivela","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"R29-14-20210131","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/1541-0420.00063","article-title":"Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials.","volume":"59","author":"Gilbert","year":"2003","journal-title":"Biometrics"},{"key":"R30-14-20210131","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1097\/QAD.0b013e328312c756","article-title":"Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression.","volume":"22","author":"Modjarrad","year":"2008","journal-title":"AIDS"},{"key":"R31-14-20210131","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00002030-200103300-00012","article-title":"Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model.","volume":"15","author":"Chakraborty","year":"2001","journal-title":"AIDS"},{"key":"R32-14-20210131","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1086\/510909","article-title":"Estimating the benefit of an HIV-1 vaccine that reduces viral load set point.","volume":"195","author":"Gupta","year":"2007","journal-title":"J Infect Dis"},{"key":"R33-14-20210131","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1097\/QAD.0b013e3282eee70c","article-title":"A strategy for accelerating the development of preventive AIDS vaccines.","volume":"21","author":"Excler","year":"2007","journal-title":"AIDS"},{"key":"R34-14-20210131","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1089\/088922203322493067","article-title":"Gp120-alum boosting of a Gag-Pol-Env DNA\/MVA AIDS vaccine: poorer control of a pathogenic viral challenge.","volume":"19","author":"Buge","year":"2003","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R35-14-20210131","doi-asserted-by":"crossref","first-page":"13026","DOI":"10.1073\/pnas.0404739101","article-title":"Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein.","volume":"101","author":"Staprans","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R36-14-20210131","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1086\/432734","article-title":"HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1 infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccine.","volume":"192","author":"Gilbert","year":"2005","journal-title":"J Infect Dis"},{"key":"R37-14-20210131","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0895-4356(00)00258-4","article-title":"Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation.","volume":"54","author":"Gilbert","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"R38-14-20210131","doi-asserted-by":"crossref","first-page":"10745","DOI":"10.1128\/JVI.76.21.10745-10755.2002","article-title":"Intrapatient diversity and its correlation with viral setpoint in human immunodeficiency virus type 1 CRF02_A\/G-IbNG iA\/G-IbNG infection.","volume":"76","author":"Mani","year":"2002","journal-title":"J Virol"},{"key":"R40-14-20210131","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200908150-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:24:25Z","timestamp":1618039465000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200908150-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181a44700","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}